Grantham, Mayo, Van Otterloo & Co (GMO)
STJ

Grantham, Mayo, Van Otterloo & Co (GMO)’s St Jude Medical STJ Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-730,986
Closed -$58.6M – 680
2016
Q4 		$58.6M Sell
730,986
-513,458
-41% -$40.8M 0.32% 87
2016
Q3 		$99.3M Sell
1,244,444
-128,524
-9% -$10.4M 0.47% 49
2016
Q2 		$107M Buy
1,372,968
+615,813
+81% +$43.9M 0.44% 54
2016
Q1 		$41.6M Sell
757,155
-35,100
-4% -$1.91M 0.16% 131
2015
Q4 		$48.9M Sell
792,255
-71,441
-8% -$4.51M 0.18% 106
2015
Q3 		$54.5M Sell
863,696
-461,674
-35% -$33M 0.19% 101
2015
Q2 		$96.8M Sell
1,325,370
-189,357
-13% -$13.7M 0.31% 68
2015
Q1 		$99.1M Sell
1,514,727
-180,449
-11% -$12M 0.3% 64
2014
Q4 		$110M Sell
1,695,176
-107,165
-6% -$6.9M 0.3% 61
2014
Q3 		$108M Buy
1,802,341
+66,303
+4% +$4.33M 0.29% 61
2014
Q2 		$120M Buy
1,736,038
+931,461
+116% +$60.4M 0.33% 56
2014
Q1 		$52.6M Buy
804,577
+580,173
+259% +$37.8M 0.14% 91
2013
Q4 		$13.9M Buy
224,404
+16,971
+8% +$983K 0.03% 178
2013
Q3 		$11.1M Sell
207,433
-16,430
-7% -$846K 0.03% 206
2013
Q2 		$10.2M Buy
+223,863
New +$9.7M 0.03% 200

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s STJ Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 730,986 shares — an estimated $58.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $120M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 730,986 St Jude Medical shares in Q1 2017, an estimated $58.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s St Jude Medical position peaked at $120M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.